immunoinflammatory

Interleukin-17 Inhibitor Shows High Efficacy After One Year of Therapy in Psoriasis Patients

New Delhi, April 28, 2018: In March 2018, BIOCAD analyzed results from its Phase II study in which the original…

7 years ago